Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00254605 · ClinicalTrials.gov registry record

Retinal Imaging in Patients With Inherited Retinal Degenerations

A clinical trial of Retinitis Pigmentosa, sponsored by University of California, San Francisco.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT00254605 is a study of Retinitis Pigmentosa that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 400 participants, above the 251-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00254605, a study of Retinitis Pigmentosa, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).

Conditions Studied

Study Locations (1)

California

  • Department of Ophthalmology Retinal Degenerations Clinic, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2005-11-01
Est. Completion 2028-11

What the Registry Record Tells You About NCT00254605

The ClinicalTrials.gov registry entry for NCT00254605 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (59% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 0 interventions.

NCT00254605 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00254605 about?

NCT00254605 is a clinical study titled "Retinal Imaging in Patients With Inherited Retinal Degenerations". The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).

What is the current status of trial NCT00254605?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2005-11-01. Estimated completion is 2028-11.

What conditions does trial NCT00254605 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

Who is sponsoring clinical trial NCT00254605?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00254605 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.